Author details

Full Name

Yotam Drier

Affiliation

ORCID

Career Start Year

2011

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37379322	Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.		2023
37561814	SARS-CoV-2 infection perturbs enhancer mediated transcriptional regulation of key pathways.		2023
36450256	Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma.	Cell Rep	2022
35867228	Simultaneous Mapping of Enhancers and Enhancer Rearrangements with Paired-End H3K27ac ChIP-seq.	Methods in Molecular Biology	2022
33227818	Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.	Blood	2021
32841603	Large-Scale Topological Changes Restrain Malignant Progression in Colorectal Cancer.	Cell	2020
32585353	Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection.	Clin Microbiol Infect	2020
31324888	Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.	Oncogene	2019
31666694	Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs.	Nature	2019
31501535	Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.	Nat Med	2019
31263286	Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.	Nat Med	2019
29051323	Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM.	Clin Cancer Res	2018
27941797	SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.	Nat Genet	2017
28891793	Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.	Elife	2017
27807282	Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.	Sci Transl Med	2016
26829750	An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.	Nat Genet	2016
26700815	Insulator dysfunction and oncogene activation in IDH mutant gliomas.	Nature	2016
26687680	A Multiplexed System for Quantitative Comparisons of Chromatin Landscapes.	Mol Cell	2016
26229090	Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.	Cancer Discov	2015
25924064	Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation.	Nature	2015
23124520	Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability.	Genome Res	2013
23770567	Mutational heterogeneity in cancer and the search for new cancer-associated genes.	Nature	2013
23622249	Punctuated evolution of prostate cancer genomes.	Cell	2013
23547110	Pathway-based personalized analysis of cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013
22622578	Melanoma genome sequencing reveals frequent PREX2 mutations.	Nature	2012
22800726	Paired-end sequencing of Fosmid libraries by Illumina.	Genome Res	2012
21596316	Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.	Mol Cell	2011
21892161	Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.	Nat Genet	2011
21423753	Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?	PLoS ONE	2011
21430775	Initial genome sequencing and analysis of multiple myeloma.	Nature	2011
21307934	The genomic complexity of primary human prostate cancer.	Nature	2011